Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Oculogenex Inc. maintains 1 pending office action in its prosecution pipeline. This action is assigned to 1 distinct examiner, Kimberly A Aron, who is responsible for the company's entire current pending workload at the patent office.
Kimberly A Aron is the busiest examiner for the entity with 1 pending matter. This singular focus suggests that the company's current patenting efforts are concentrated on a single application, as shown by the 1 pending office action currently being managed by this examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ARON, KIMBERLY A | 1 | 54.5% | +35.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18760919 | AAV-MEDIATED GENE TRANSFER FOR RETINOPATHY | ARON, KIMBERLY A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18760919 | AAV-MEDIATED GENE TRANSFER FOR RETINOPATHY | ARON, KIMBERLY A | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18760919 | AAV-MEDIATED GENE TRANSFER FOR RETINOPATHY | ARON, KIMBERLY A | — | §102§112 | Non-Final OA | — | Pending | Jul 01, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial